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In Brief
NDR/LATS kinases are known primarily
for their role in controlling cell and tissue
proliferation andmorphogenesis, e.g., via
regulation of transcription in the Hippo
pathway. Using fission yeast S. pombe as
a model system, Tay et al. show that the
NDR/LATS kinase Orb6 is a major
regulator of exocytosis.
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https://doi.org/10.1016/j.celrep.2019.01.027SUMMARY
NDR/LATS kinases regulate multiple aspects of cell
polarity and morphogenesis from yeast to mammals.
Fission yeast NDR/LATS kinase Orb6 has been pro-
posed to control cell polarity by regulating the
Cdc42 guanine nucleotide exchange factor Gef1.
Here, we show that Orb6 regulates polarity largely
independently of Gef1 and that Orb6 positively regu-
lates exocytosis. Through Orb6 inhibition in vivo and
quantitative global phosphoproteomics, we identify
Orb6 targets, including proteins involved in mem-
brane trafficking. We confirm Sec3 and Sec5,
conserved components of the exocyst complex, as
substrates of Orb6 both in vivo and in vitro, and we
show that Orb6 kinase activity is important for exo-
cyst localization to cell tips and for exocyst activity
during septum dissolution after cytokinesis. We
further find that Orb6 phosphorylation of Sec3 con-
tributes to exocyst function in concert with exocyst
protein Exo70. We propose that Orb6 contributes to
polarized growth by regulating membrane trafficking
at multiple levels.
INTRODUCTION
Theability to establish,maintain, andalter polarity is central to the
function of nearly all eukaryotic cell types (Campanale et al.,
2017; Mayor and Etienne-Manneville, 2016; Rodriguez-Boulan
and Macara, 2014; Schelski and Bradke, 2017; St Johnston
and Ahringer, 2010). Dysregulation of cell polarity is associated
with multiple pathologies, including tumorigenesis and neurode-
generative disease (Martin-Belmonte and Perez-Moreno, 2011;
Millecamps and Julien, 2013). NDR/LATS kinases are members
of a subfamily of the AGC serine-threonine kinases and are
important for polarized cellular differentiation in multiple systems
(Hergovich et al., 2006). NDR/LATS kinases such as Trc
(Drosophila), NDR1 and NDR2 (NDR1/2) (mammals), and SAX-1654 Cell Reports 26, 1654–1667, February 5, 2019 ª 2019 The Auth
This is an open access article under the CC BY license (http://creative1/SAX-2 (C. elegans) share evolutionarily conserved functions
in coordinating neurite branching and patterning of neuronal
fields (Hergovich, 2016). Other NDR/LATS kinases such as Wts
(Drosophila), LATS1 and LATS2 (LATS1/2) (mammals) and
WTS-1 (C. elegans) regulate polarized differentiation of
epithelia and other cell types (Furth and Aylon, 2017). In
budding yeast Saccharomyces cerevisiae and fission yeast
Schizosaccharomyces pombe, NDR/LATS kinases Cbk1 and
Orb6, respectively, are required for polarized cellular morpho-
genesis (Bidlingmaier et al., 2001; Racki et al., 2000; Verde
et al., 1998). Other essential biological processes regulated by
NDR/LATS kinases include centrosome duplication, cell-cycle
progression, autophagy, and apoptosis (Hergovich, 2016).
Identification of targets of NDR/LATS kinases is crucial for un-
derstanding how they regulate complex biological processes. To
date, surprisingly few targets of NDR/LATS kinases are known
(Hergovich, 2013). The best characterized targets in mammals
and Drosophila are the transcriptional co-activators YAP and
TAZ (targets of LATS1/2) and Yki (target of Wts), respectively
(Yu and Guan, 2013). Phosphorylation of YAP, TAZ, and Yki is
an important element of the Hippo pathway, a tumor suppressor
pathway regulating cell shape and proliferation (Hansen et al.,
2015). In addition, NDR1/2 phosphorylate p21 cyclin-dependent
kinase inhibitor and MYPT1 phosphatase, which regulate the
G1/S transition and G2 DNA damage checkpoint, respectively
(Chiyoda et al., 2012; Cornils et al., 2011). In neurons, NDR1/2
phosphorylate AP2-associated kinase 1 (AAK1) and Rabin8,
the guanine nucleotide exchange factor (GEF) for Rab8 guano-
sine triphosphatase (GTPase), which are involved in vesicle
trafficking and are important for dendrite growth regulation and
dendritic spine development, respectively (Ultanir et al., 2012).
In budding yeast, Cbk1 inactivation or inhibition affects both
cell morphogenesis and asymmetry of gene expression between
mother and daughter cell. Cbk1 phosphorylates the transcription
factor Ace2 and the RNA-binding protein Ssd1, a translational
regulator (Weiss, 2012). Cbk1 is also reported to phosphorylate
Sec2, a GEF for the Rab GTPase Sec4 (Kurischko et al., 2008).
In fission yeast, temperature-sensitive orb6-25 mutants lose
polarity at non-permissive temperature, and cells become round
rather than rod shaped (Verde et al., 1998). In vitro, Orb6 canors.
commons.org/licenses/by/4.0/).
phosphorylate the Ssd1 homolog Sts5 (Nun˜ez et al., 2016), as
well as Gef1, a GEF for the Rho-family cell-polarity GTPase
Cdc42 (Das et al., 2015). Phosphorylation of Gef1 serine-112 is
thought to promote Gef1 association with 14-3-3 protein
Rad24, restricting Gef1’s ability to activate Cdc42 (Das et al.,
2015). Accordingly, Orb6 inactivation leads to ectopic localiza-
tion of active Cdc42 (Cdc42-GTP) on cell sides, with subsequent
recruitment of formin For3 to these ectopic sites (Das et al.,
2009). These events have been proposed to drive reorganization
of actin cable nucleation and redirection of intracellular trans-
port, leading to increased cell width in Orb6-inhibited cells
(Das et al., 2009).
Hereweshow, in contrast to previouswork, that several pheno-
types associated with Orb6 inactivation, including increased cell
width, are independent of Gef1. We further find that
Orb6 positively regulates exocytosis, also independently of
Gef1. To identify novel targets of Orb6, we performed quanti-
tative global phosphoproteomics analyses of cells with
decreased Orb6 kinase activity and generated a high-quality
dataset of Orb6 targets in vivo. Targets include proteins involved
in kinase signaling, membrane trafficking, and the exocyst
complex, a conserved octameric complex involved in late
stages of exocytosis (Kee et al., 1997; TerBush and Novick,
1995). The exocyst,which contains proteins that bind to secretory
vesicles, as well as proteins that bind to the plasma membrane,
mediates secretory vesicle docking to the plasma membrane
before SNARE-mediated vesicle fusion (Heider and Munson,
2012; Wu and Guo, 2015). We show that Orb6 phosphorylates
exocyst proteins in vitro and that exocyst phosphorylation in vivo
mediates a subset of Orb6-dependent phenotypes. Overall, our
results suggest that Orb6 regulates cell polarity via multiple tar-
gets involved in membrane trafficking and exocytosis.
RESULTS
Several Cell Growth and/or Polarity Phenotypes after
Orb6 Inhibition In Vivo Are Gef1 Independent
Protein kinase function in vivo can be studied by mutating gate-
keeper residues in the kinase ATP-binding pocket, making
kinase activity sensitive to cell-permeable, nucleotide-competi-
tive analogs (Bishop et al., 2000). An analog-sensitive orb6 allele
driven by the high-strength nmt1 promoter has been described
previously (Das et al., 2009). To investigate Orb6 function at
native expression levels, we introduced the same mutation
(M170A) at the endogenous orb6 locus; throughout this work,
we refer to our new allele as orb6-as2. We inhibited Orb6-as2
using the nucleotide competitive analog 3-BrB-PP1, although
other analogs were equally effective (Figures S1A and S1B).
For simplicity, we will refer to orb6-as2 cells treated with
3-BrB-PP1 as Orb6-inhibited cells. Consistent with previous
work (Das et al., 2009; Nun˜ez et al., 2016), Orb6 inhibition in vivo
led to an increase in cell width, partial ectopic localization of
Cdc42-GTP (imaged with CRIB-3mCitrine) (Mutavchiev et al.,
2016) and the actin cytoskeleton away from cell tips (i.e., on
cell sides), and cell-separation defects during septation (Figures
1A, 1C, S1C, and S1D; Video S1). These phenotypes were spe-
cific to orb6-as2 cells treated with 3-BrB-PP1 (Figures 1C and
S1B; Videos S2 and S3). Also consistent with previous work,ectopic localization of Cdc42-GTP and actin in Orb6-inhibited
cells was suppressed by gef1D (Figures 1A, S1C, and S1D;
Video S1) (Das et al., 2009).
However, in apparent contrast to the same previous work (Das
et al., 2009), we found that increased cell width in Orb6-inhibited
cellswasnot suppressedbygef1D (Figures 1Aand1C;VideoS1).
Because this work had investigated gef1D suppression of cell-
width increase only in temperature-sensitive orb6-25 mutants,
not in Orb6-inhibited cells, we also examined orb6-25 cells. The
width increase of orb6-25 cells at 37C (restrictive temperature)
was greater than that of Orb6-inhibited cells at 25C, with many
orb6-25 cells becoming round (Figures 1B, 1C, and S1B) (Verde
et al., 1998). We found that this difference can be attributed to
the high temperature required to reveal the orb6-25 phenotype,
because Orb6 inhibition by 3-BrB-PP1 at 37C also led to a
greater width increase (Figure 1C). We suggest that the original
orb6-25 phenotype (Verde et al., 1998) is a synthetic phenotype
that depends on both temperature-dependent inactivation of
orb6 function and increased temperature. In any case, similar to
Orb6-inhibited cells, we found that width increase in orb6-25 cells
was not suppressed by gef1D, although a small proportion
(15%) of orb6-25 gef1D cells at restrictive temperature dis-
playedwidthswithin the rangeoforb6-25andorb6-25gef1D cells
at permissive temperature (Figures 1B and 1C).
Time-lapse observation of Cdc42-GTP localization revealed
that Orb6-inhibited cells almost completely ceased to elongate,
even when they remained largely polarized (based on Cdc42-
GTP retention at cell tips) (Figures 1D and 1E; Video S4). This
was surprising, because Cdc42-GTP enrichment on the plasma
membrane is normally closely correlated with active cell growth
(Figure S1E) (Tatebe et al., 2008). Cessation of elongation also
occurred in Orb6-inhibited gef1D cells (Figures 1D–1G; Video
S4), which do not show ectopic Cdc42-GTP localization. Further
analysis indicated that cell-volume expansion over time is signif-
icantly decreased in Orb6-inhibited cells (both wild-type and
gef1D) (Figures 1E–1G) (see STAR Methods); that is, cell
widening in Orb6-inhibited cells does not compensate for cessa-
tion of cell elongation.
We conclude that in addition to increased cell width and
impaired cell separation, a key phenotype associated with Orb6
inhibition in vivo is the cessation of cell elongation, independent
of changes in Cdc42-GTP at cell tips. Moreover, cessation of
elongation is accompanied by a decreased rate of cell-volume
expansion. Finally, unlike ectopic localization of Cdc42-GTP
and actin after Orb6 inhibition, these other important phenotypes
are not suppressed by gef1D.
Orb6 Inhibition Leads to a Strong Decrease in
Exocytosis
To further characterize cessation of elongation and decreased
cell-volume expansion in Orb6-inhibited cells, we imaged
mCherry-tagged beta-glucan synthase subunit Bgs4, a multi-
pass transmembrane protein required for cell wall synthesis at
sites of active growth (i.e., cell tips during interphase and the
cell midzone during cytokinesis) (Figure S1E) (Corte´s et al.,
2005, 2015). Within 12–15 min after Orb6 inhibition, Bgs4 was
almost completely lost from cell tips in both wild-type (i.e.,
gef1+) and gef1D backgrounds, although in a small proportionCell Reports 26, 1654–1667, February 5, 2019 1655
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Figure 1. Orb6 Inhibition Leads to Increased Cell Width, Cell-Separation Defects, and Cessation of Polarized Elongation in Both Wild-Type
and gef1D Cells
(A) Video time points of Cdc42-GTP reporter CRIB-3mCitrine after Orb6 inhibition (3-BrB-PP1 treatment of orb6-as2) in indicated strains. 3-BrB-PP1 was
added after the 0 time point. Both strains show cell-width increase and cell-separation defects. Video S1 shows more cells, with Lifeact-3mCherry. Green
arrowheads indicate ectopic CRIB-3mCitrine on cell sides in orb6-as2 cells, but not orb6-as2 gef1D cells. Red arrowheads indicate CRIB-3mCitrine at the
midzone during early stages of septation in orb6-as2 cells. Blue arrowheads indicate the absence of CRIB-3mCitrine at comparable stages in orb6-as2 gef1D
cells (Video S1).
(B) Morphology of indicated strains at 25C and after 5 h at 37C, shown by fluorescein-dextran exclusion. Images of this type were used for cell-width mea-
surements in (C).
(C) Cell width in indicated strains after 5 h of the indicated treatment and/or condition. Diagrams illustrate how width was measured. Red lines and error bars
indicate median and interquartile range.
(D) Kymographs of CRIB-3mCitrine in indicated strains, starting 1 h after 3-BrB-PP1 addition. Video S4 shows the same cells. Orb6-inhibited cells do not
elongate, despite Cdc42-GTP enrichment at cell tips.
(E–G) Rates of cell elongation (E), cell widening (F), and cell-volume expansion (G) from experiments as in (D). Red lines and error bars indicate mean and SD. Cell-
volume expansion is derived from the other two parameters (see STAR Methods). Videos show that slightly positive values for cell elongation rates in orb6-as2
and orb6-as2 gef1D cells are due to cell swelling in all directions and not to polarized elongation (Video S4).
n shows the number of cells scored. Scale bars, 5 mm. p valueswere determined by two-tailed unpairedMann-Whitney test. See also Figure S1 and Videos S2 and
S3. Three biological replicates were performed for (A) and (D). Measurements for (E)–(G) weremade fromone of the replicates. Imaging experiments for (B) and (C)
were performed once.of gef1D cells, some Bgs4 remained either at or just underneath
cell tips (Figures 2A, 2B, and 2D; Video S5). Loss of Bgs4 from
tips was accompanied by an increase in cytoplasmic Bgs4
puncta, suggesting that Bgs4 was now in endomembrane com-
partments. Control wild-type (orb6+) cells treated with 3-BrB-1656 Cell Reports 26, 1654–1667, February 5, 2019PP1 showed no change in mCherry-Bgs4 localization and
continued to elongate (Figures 2A and S1F).
In Orb6-inhibited cells attempting to divide, Bgs4 accumu-
lated at the septation zone for long periods (Figure 2B; Video
S5), consistent with observed cell-separation defects. Because
A B
DC
Figure 2. After Orb6 Inhibition, Integral Mem-
brane Protein Bgs4 Is Lost from the Plasma
Membrane at Interphase Cell Tips in Both Wild-
Type and gef1D Cells
(A) Video time points of mCherry-Bgs4 after Orb6 inhi-
bition in indicated strains. 3-BrB-PP1 was added after
the 0 time point. Arrowheads indicate loss of Bgs4 from
cell tips.
(B) Matched fields of cells before and after 3-BrB-PP1
addition to inhibit Orb6. Arrowheads indicate Bgs4
accumulation at the septum. Video S5 shows the same
cells.
(C) Video time points of mCherry-Bgs4 after Orb6
inhibition in hydroxyurea-arrested (G1/S) cells. Arrow-
heads indicate sustained loss of Bgs4 from cell tips,
independent of karyokinesis. The asterisk indicates a
cluster of endocytosed Bgs4 under the plasma mem-
brane. Video S5 shows more cells, including these.
(D) Quantification of mCherry-Bgs4 cell-tip localization
in indicated strains 120 min after 3-BrB-PP1 addition.
n shows the number of cells scored. Scale bars, 10 mm.
See also Figure S1. Three biological replicates were
performed for (A) and (B), and two biological replicates
were performed for (C).nearly all Orb6-inhibited interphase cells eventually progress into
mitosis, we wanted to confirm that loss of Bgs4 from cell tips
after Orb6 inhibition during interphase was not obligately associ-
ated with later recruitment of Bgs4 to the cell midzone during
division. We therefore arrested orb6-as2 or orb6-as2 gef1D cells
in G1/S with hydroxyurea and then inhibited Orb6. In both cases,
Bgs4 was quickly lost from cell tips for the duration of imaging
(2 h) (Figures 2C and 2D; Video S5). Collectively, these results
suggest that Orb6 kinase activity is essential for maintaining
plasma membrane localization of Bgs4, and hence cell elonga-
tion, at interphase cell tips.
Because Bgs4 is a multipass transmembrane protein, we
would expect its disappearance fromcell tips afterOrb6 inhibition
to be mediated by endocytosis. To confirm this, we blocked
endocytosis in orb6-as2 cells by depolymerizing the actin cyto-
skeleton with latrunculin A (Ayscough, 2005) and then inhibited
Orb6. In these cells, Bgs4 remained at cell tips for at least 2 h after
Orb6 inhibition (Figure3A;VideoS6), strongly suggesting that loss
of Bgs4 fromcell tips after Orb6 inhibition occurs via endocytosis.
These findings suggested that loss of Bgs4 from cell tips after
Orb6 inhibition may be due to impaired exocytosis in the pres-
ence of continued endocytosis. This would also explain, at least
partly, both the cessation of cell elongation during interphase and
the cell-separation defects during cell division (due to inability to
dissolve the primary septum) (Martı´n-Cuadrado et al., 2003;
Wang et al., 2002). To test whether exocytosis is impaired inCellOrb6-inhibited cells, we measured secretion
of acid phosphatase (ACP) activity (Wang
et al., 2002) into the culture medium. In con-
trol-treated orb6-as2 and orb6-as2 gef1D
cells, ACP secretion was similar to that in
wild-type cells (Figure 3B). By contrast, in
Orb6-inhibited cells (both gef1+ and gef1D),
ACP secretion was sharply decreased.(Figure 3B). These results suggest that Orb6 positively regulates
exocytosis and that this regulation is independent of Gef1.
In these experiments, we noticed that 3-BrB-PP1-treated
wild-type cells showed higher (4-fold) ACP secretion than
control-treated wild-type cells (Figure 3B). In mass spectrometry
experiments associated with phosphoproteomics analysis after
Orb6 inhibition (described later), we found that 3-BrB-PP1 treat-
ment leads to increased intracellular levels of the major acid
phosphatase Pho1 (Figure S2B). Increased Pho1 levels likely
account for the increased ACP secretion seen in 3-BrB-PP1-
treated wild-type cells as a result of mass action. 3-BrB-PP1
treatment also led to increased intracellular Pho1 levels in
orb6-as2 cells (Figure S2B), even though these cells showed
decreased ACP secretion. These results indicate that the
decrease in ACP secretion observed in Orb6-inhibited cells is
due to a specific decrease in exocytosis and is not simply due
to a decrease in ACP levels relative to uninhibited cells.
To further investigate the role of Orb6 in exocytosis, we
measured fluorescence recovery after photobleaching (FRAP)
of the plasma membrane t-SNARE Psy1 in Orb6-inhibited cells
(Figures 3C and 3D). Psy1 is a single-pass transmembrane
protein distributed approximately uniformly on the plasmamem-
brane (Bendezu´ et al., 2015; Maeda et al., 2009). Previous FRAP
experiments showed that GFP-Psy1 recovers fluorescence
when bleached at cell tips, but not when bleached at cell sides
(Bendezu´ et al., 2015); this implies that Psy1 is not highly mobileReports 26, 1654–1667, February 5, 2019 1657
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Figure 3. Exocytosis Defects in Wild-Type and gef1D Cells after Orb6 Inhibition
(A) Video time points of mCherry-Bgs4 after combining actin depolymerization by latrunculin A (LatA) with Orb6 inhibition. Prior disruption of endocytosis by LatA
prevents loss of Bgs4 from cell tips after Orb6 inhibition (compare with Figure 2A). Video S6 showsmore cells, including this cell, together with gef1D cells treated
in the same way.
(B) Secretion of acid phosphatase (ACP) activity into culture medium in indicated strains after treatment with methanol (left) or 30 mM 3-BrB-PP1 (right). Graphs
show mean ACP activity normalized to cell density from replicate experiments. Error bars show SEM.
(C) Fluorescence recovery after photobleaching (FRAP) of plasmamembrane t-SNAREGFP-Psy1 at cell tips in orb6-as2 cells under the indicated conditions. The
top-left diagram shows the target bleaching zone (magenta), line scan along the plasma membrane (green), and bleached portion of the plasma membrane
(orange). The top images are from representative experiments. The bottom images are corresponding kymographs based on the line scan and bleached portion
shown in the diagram.
(D) Quantification of FRAP from experiments as in (C) (see STARMethods). Symbols indicate mean values. Error bars indicate SD. n indicates the number of cells
analyzed.
Scale bars, 10 mm. The imaging experiment for (A) was performed once. For (B), four biological replicates were performed for wild-type and orb6-as2 cells, and
two biological replicates were performed for orb6-as2 gef1D cells. Two biological replicates of FRAP imaging were performed for (C).in the plane of the plasmamembrane and that Psy1 fluorescence
recovery at cell tips is due primarily to turnover via endo- and
exocytosis. Consistent with previous work, GFP-Psy1 bleached
at control interphase cell tips recovered to approximately 80%of
pre-bleaching levels within 20 min after bleaching (Figure 3D),
with essentially uniform recovery across the bleached region
(Figure 3C). By contrast, GFP-Psy1 bleached at Orb6-inhibited
cell tips showed little recovery. As an additional control, we
bleached GFP-Psy1 at control cell tips during septation, when
membrane trafficking is concentrated at the cell midzone rather
than cell tips; in these cells, we also observed little fluorescence
recovery. Collectively, these results suggest that decreased fluo-
rescence recovery of GFP-Psy1 at cell tips inOrb6-inhibited cells
is due to defects in exocytic membrane trafficking.
We conclude that inhibition of Orb6 kinase activity impairs
exocytosis independent of Gef1.1658 Cell Reports 26, 1654–1667, February 5, 2019Identification of Orb6 Substrates by Quantitative Global
Phosphoproteomics
To date, the only reported substrates of Orb6 are Gef1 and Sts5,
both of which were phosphorylated in vitro by Orb6 in immuno-
precipitates of the Orb6 coactivator Mob2 (Das et al., 2015;
Nun˜ez et al., 2016; Wiley et al., 2003). Sts5 is not known to be
associated with exocytosis, and our results indicate that
decreased exocytosis after Orb6 inhibition does not involve
Gef1. This suggested that other, unknown substrates of Orb6
may regulate exocytosis.
To identifyOrb6 substrates, we combined stable isotope label-
ing with amino acids in culture (SILAC) (Bicho et al., 2010; Macek
et al., 2017; Ong and Mann, 2006) with global phosphoproteo-
mics analysis (Figure S2A). We treated light- and heavy-labeled
orb6-as2 cells with either methanol (control) or 3-BrB-PP1 and
quantitatively analyzed phosphopeptides by mass spectrometry
A B
C
Figure 4. Identification of Orb6 Targets In Vivo
by Quantitative Global Phosphoproteomics
(A)Correlation of changes in phosphorylation afterOrb6
inhibition for 2,415 quantified phosphosites common to
two biological replicate experiments (R1 and R2). Axes
show log2(fold change) in phosphorylation of individual
phosphosites. The yellow region indicates phospho-
sites with 2-fold or greater decreased phosphorylation
after Orb6 inhibition in both experiments. The blue re-
gion indicates relative scarcity of phosphosites with
equivalent increase in phosphorylation. Phosphosites
Sec3 serine-201 (S201) and Sec5 serine-50 (S50) are
indicated. The inset shows Pearson correlation co-
efficients for three biological replicates (Table S1).
(B) Match of highest-confidence and highest-ranking
Orb6-dependent phosphosites to the NDR/LATS
consensus (HxR/H/KxxS/T). All indicated phosphosites
were quantified in all three biological replicates and
showed 2-fold or greater decreased phosphorylation
after Orb6 inhibition. Phosphosites were ranked by fold
decrease in phosphorylation, independent of whether
they matched the NDR/LATS motif (Table S2).
(C) Enrichment of gene ontology terms associated with
genes shown in (B), based on molecular function, bio-
logical process, and cellular component ontologies. p
valuesweredeterminedbyGeneticGeneOntology (GO)
Term Finder.
See also Figures S2 and S3.to identify phosphosites with decreased phosphorylation after
Orb6 inhibition (see STAR Methods). Phosphopeptide abun-
dancewasnormalized to the abundanceof the relevant individual
proteins, and to control for possible off-target effects of 3-BrB-
PP1, we analyzed phosphopeptides in wild-type cells treated
with 3-BrB-PP1.
Overall results from SILAC phosphoproteomics are presented
inTableS1. From threebiological replicate experiments,we iden-
tified 10,866 phosphosites, of which 8,134 phosphosites could
be quantified. Among the quantified phosphosites, 326 (4%)
showed a 2-fold or greater decrease in phosphorylation after
Orb6 inhibition in at least one experiment, 121 (1.5%) showed
this decrease in at least two experiments, and 55 (0.7%) showed
this decrease in all three experiments (Table S2). Correlation be-
tween replicate experiments is shown in Figure 4A.
Because phosphosites with decreased phosphorylation after
Orb6 inhibition could be either direct or indirect targets of
Orb6, we compared them to the NDR/LATS consensus motif,
HxR/H/KxxS/T (Hao et al., 2008; Mazanka et al., 2008; Zhao
et al., 2007). Among the 55 phosphosites with significantly
decreased phosphorylation in all three experiments, 36 (65%)
contained a basic amino acid (histidine, arginine, or lysine) at
the 3 position relative to the phosphorylated residue (Figures
4B, S2C, and S2D; Table S2). NDR/LATS kinases are unique
among AGC-family kinases (and possibly among all character-
ized serine-threonine kinases) in their strong preference for his-
tidine at the 5 position (Hao et al., 2008; Pearce et al., 2010).
Among the 15 phosphosites with 4-fold or greater decreased
phosphorylation in all three experiments, 12 showed a perfect
match to the NDR/LATS consensus, including histidine at the
5 position, suggesting that they are direct Orb6 targets (Fig-
ure 4B; Table S2).Gene Ontology (GO) analysis of proteins with the highest-
ranking phosphosites matching the NDR/LATS consensus
revealed specific enrichment for GO terms related to protein
kinase signaling (Cek1, Ppk1, Ppk15, and Ppk25), exocytosis
and phosphatidylinositol binding (Pep7, Sec3, Sec5, and
Osh2), and the exocyst complex (Sec3 and Sec5) (Figure 4C).
Given the importance of the exocyst complex for docking secre-
tory vesicles at the plasma membrane before membrane fusion
during exocytosis (Heider and Munson, 2012; Wu and Guo,
2015), we focused further attention on exocyst proteins Sec3
and Sec5, which showed decreased phosphorylation on resi-
dues serine-201 and serine-50, respectively.
Orb6 Inhibition Leads to Exocyst Dephosphorylation and
Loss from Cell Tips
To confirm Orb6-dependent phosphorylation of Sec3 and Sec5,
we combined SILAC with Sec5 immunoprecipitation to analyze
exocyst phosphorylation in control versus Orb6-inhibited cells.
In Sec5-mCherry immunoprecipitates, levels of all other exocyst
proteins (Sec3, Sec6, Sec8, Sec10, Sec15, Exo70, and Exo84)
were similar between control andOrb6-inhibited cells, suggesting
that exocyst assembly is not grossly affected by Orb6 inhibition
(Figures S3A and S3B). Consistent with global phosphoproteo-
mics data, immunoprecipitates fromOrb6-inhibited cells showed
decreased phosphorylation of Sec3 serine-201 and Sec5 serine-
50, as well as decreased phosphorylation of a novel site, Sec8
serine-440 (Figures S3C and S3D; the Sec8 site does not corre-
spond to the NDR/LATS consensus). We also found that unlike
Sec5 and Sec8, Sec3 contains numerous additional phospho-
siteswithmodestly increased or decreasedphosphorylation after
Orb6 inhibition (Figures S3C and S3D). No other significant differ-
ences in exocyst phosphorylation were observed.Cell Reports 26, 1654–1667, February 5, 2019 1659
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Figure 5. Orb6 Phosphorylates Sec3 and Sec5 In Vitro
(A) SDS-PAGE of in vitro kinase reactions using recombinant GST-Sec3 or GST-Sec5 (red asterisks) incubated with buffer alone or with Mob2-GFP immuno-
precipitates from sts5D or sts5D orb6D cells. Phosphosites identified bymass spectrometry (MS) in each reaction are shown below, with associated probabilities
(in parentheses) for the precise location of the phosphorylated residue. In some cases, the precise location is ambiguous due to incomplete sets of b and y ions.
Residues with very high probabilities are shown in bold.
(B and C) Tandem mass spectrometry (MS/MS) spectra of phosphopeptides indicating phosphorylation of Sec3 serine-201 (B) and Sec5 serine-50 (C). b and y
ions marked with asterisks indicate neutral loss of 98 Da, an additional diagnostic for the phosphorylated residue. Note different intensity scales in (B) and (C).
In vitro kinase reactions and phosphomapping were performed once.To demonstrate Orb6 phosphorylation of Sec3 and Sec5
in vitro, we performed kinase assays on bacterially expressed re-
combinant glutathione S-transferase (GST)-Sec3 and GST-Sec5
using Mob2-GFP immunoprecipitates as a source of active Orb6
(Figure 5A). Because Orb6 is normally essential for viability and
viable orb6D cells can be recovered only in a sts5D background
(Nun˜ez et al., 2016), we immunoprecipitated Mob2-GFP from
sts5D cells for the kinase reaction and from sts5D orb6D cells
as negative control. Consistent with global phosphoproteomics,
we identified phosphorylation of Sec3 serine-201 and Sec5
serine-50 in reactions prepared from sts5D cells, but not from
sts5D orb6D cells or buffer-only controls (Figures 5B–5D). These
phosphorylations were highly specific, because only one other
site (Sec5 tyrosine-458) was phosphorylated in vitro in an
Orb6-dependent manner (Figure 5B).
We next examined how Orb6 inhibition affects exocyst protein
localization in vivo. In untreated orb6-as2 cells, fluorescent-
tagged exocyst proteins Sec3, Sec5, Sec8, and Exo70 localized
to cell tips in interphase and the septation zone during division,
while after Orb6 inhibition, these proteins showed decreased
localization at cell tips and ectopic puncta on the peripheral
cortex (Figure 6; Video S7). By contrast, 3-BrB-PP1-treated
wild-type (orb6+) cells displayed normal exocyst localization1660 Cell Reports 26, 1654–1667, February 5, 2019(Figure S4). It is unclear whether decreased exocyst localization
at cell tips is a direct consequence of Orb6 inhibition or an indi-
rect consequence (e.g., due to impaired exocytosis). After Orb6
inhibition, exocyst proteins also showed prolonged localization
to the septation zone, consistent with cell-separation defects.
The cell-separation defect caused by Orb6 inhibition mimics
the consequences of inactivating exocyst in fission yeast (Bend-
ezu´ et al., 2012; Jourdain et al., 2012; Wang et al., 2002).
Altogether, our results indicate that Orb6 phosphorylates exo-
cyst proteins, and Orb6 kinase activity is important for exocyst
localization to the cell tip during interphase and for exocyst func-
tion in septum dissolution after cytokinesis.
Phosphorylation of Sec3 Serine-201 Is Important for
Exocyst Function
To test the role of Sec3 serine-201 and Sec5 serine-50 phos-
phorylation in exocytosis, we mutated these residues to non-
phosphorylatable alanine at their endogenous loci to make the
mutants sec3-S201A and sec5-S50A. Both single mutants, as
well as a sec3-S201A sec5-S50A doublemutant, were viable un-
der normal growth conditions at 25C and 36C (Figures 7 and
S5A). Because sec5D cells are inviable (Hayles et al., 2013)
and sec3D cells are viable only when grown at 25C in the
A B C D Figure 6. Orb6 Inhibition Leads to Decreased
Exocyst at Cell Tips and Ectopic Exocyst at
Cell Sides
(A–D) Localization of the indicated fluorescent-
tagged exocyst proteins Sec3-3mCherry (A), Sec5-
3mCherry (B), Sec8-tdTomato (C), and Exo70-
mCherry (D) before and after Orb6 inhibition. 3-BrB-
PP1 was added just after the 0 time point. Asterisks
indicate decreased or undetectable fluorescence at
interphase cell tips after Orb6 inhibition. Arrowheads
indicate ectopic exocyst puncta on cell sides. White
bars indicate split exocyst localization at the septation
zone.
(A and B) Different fields were imaged for each time
point to avoid potential photobleaching.
(C and D) Signals were brighter, and the same fields
were imaged for all time points.
Video S7 shows changes in Sec3-3mCherry and
Sec5-3mCherry localization at a higher time resolu-
tion. Scale bar, 10 mm. See also Figure S4. Three
biological replicates were performed for (A) and (B).
Imaging experiments for (C) and (D) were performed
once.presence of 1 M sorbitol (Bendezu´ et al., 2012), sec3-S201A and
sec5-S50A are not complete loss-of-functionmutations. Howev-
er, in ACP secretion assays, sec3-S201A cells showed impaired
secretion relative to wild-type (Figure 7A). The sec5-S50Amuta-
tion did not affect secretion in either wild-type or sec3-S201A
backgrounds. This suggests that Sec3 serine-201 phosphoryla-
tion, but not Sec5 serine-50 phosphorylation, is important for
exocytosis.
Because cell-separation defects are observed in several exo-
cyst deletion mutants (Bendezu´ et al., 2012; Jourdain et al.,
2012; Wang et al., 2002), we assayed the septation index in
sec3-S201A and sec5-S50A mutants. Neither sec3-S201A and
sec5-S50A single mutants nor the double mutant showed an
increased septation index relative to wild-type cells (Figures
7C, 7D, and S5A). In addition, both Sec3-S201A-mCherry and
Sec5-S50A-mCherry localized to cell tips during interphase
and to the septation zone during cell division, like their wild-
type counterparts (Figure 7B).
Given these results, we asked whether the function of Sec3
and/or Sec5 phosphorylation overlaps with other exocyst com-
ponents, in particular Exo70. In fission yeast, sec3 and exo70
are redundant for viability: sec3D and exo70D mutations are
each conditional lethal, but exo70D sec3D double mutants
are dead under all conditions (Bendezu´ et al., 2012). We com-
bined sec3-S201A and sec5-S50A single and double mutants
with exo70D and assayed ACP secretion and the septation in-
dex. All mutant combinations were viable at 25C and 36CCell Rep(Figures 7 and S5A). In ACP secretion as-
says, all mutants combined with exo70D
behaved similarly to mutants in a wild-
type (exo70+) background (Figure 7A).
However, the septation index was signifi-
cantly increased in exo70D sec3-S201A
double mutants compared to either single
mutant at both 25C and 36C; more than
75% of cells contained at least one septum, and 25% of cells
contained multiple septa (Figures 7C, 7D, and S5A). This was
not altered by further deletion of gef1 (Figures S5B and S5C).
The septation index in exo70D and exo70D sec3-S201A mu-
tants was not greatly altered by the sec5-S50A mutation,
although there were somewhat fewer multi-septate exo70D
sec3-S201A sec5-S50A cells at 25C compared to 36C (Fig-
ures 7C, 7D, and S5A); the reasons for this are not yet clear.
Collectively, these observations suggest that phosphorylation
of Sec3 serine-201 by Orb6 works with Exo70 to promote exo-
cyst function in cell separation.
We hypothesized that cell-separation defects in exo70D sec3-
S201A cells might be due to Sec3-S201A failing to localize
correctly in the absence of Exo70. However, because spores
of the double-mutant exo70D sec3-S201A-3mCherry failed to
germinate (Figure S5D), we were unable to test this directly.
We therefore examined Sec5 and Sec8 localization in exo70D
sec3-S201A cells. Both proteins localized normally to cell tips
and the septation zone, indicating that exocyst localization per
se was not adversely affected (Figures S5E and S5F).
In parallel with these experiments, we constructed sec3-
S201D and sec5-S50D single and double mutants, as well as
sec3-S201E and sec5-S50E single and double mutants, to test
whether such phosphomimetic mutations could abrogate the ef-
fects of Orb6 inhibition on exocytosis. Imaging of mCherry-Bgs4
in Orb6-inhibited cells containing phosphomimetic sec3 and/or
sec5 mutations showed that this was not the case (Video S8).orts 26, 1654–1667, February 5, 2019 1661
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Figure 7. Sec3 Serine-201 Phosphorylation Contributes to Exocyst Function
(A) Secretion of ACP activity into culture medium, normalized to cell density, for indicated strains. Symbols indicate mean values. Error bars indicate SEM. Error
bars smaller than datapoint symbols are not shown.
(B) Localization of 3mCherry-tagged Sec3-S201A and Sec5-S50A to cell tips and the septation zone.
(C) Calcofluor staining of indicated strains, showing cell-separation defects in exo70D sec3-S201A and exo70D sec3-S201A sec5-S50A cells.
(D) Septation index in cells of indicated strains as in (C).
Scale bars, 10 mm. See also Figure S5 and Video S8. Three biological replicates were performed for ACP assays in (A). Imaging experiments for (B) and (C) were
performed once.After Orb6 inhibition in the phosphomimetic mutants, Bgs4 was
quickly lost from cell tips, and cell elongation ceased, as in wild-
type cells. It is possible that phosphomimetic sec3 and sec5
mutations do not fully reproduce the properties of the naturally
phosphorylated residues (Dephoure et al., 2013). Alternatively,
the collective effects of Orb6 inhibition on other Orb6 targets
(see Discussion) may be sufficient to inhibit exocytosis even
when Sec3 and Sec5 remain in a phosphorylated or phosphomi-
metic state.
DISCUSSION
Here we have shown that the conserved NDR/LATS kinase Orb6
has a major role in regulating fission yeast exocytosis. Round
and/or wide cell-polarity defects in orb6mutants were previously
attributed to failure to spatially restrict activity of Cdc42 GEF
Gef1 (Das et al., 2009). However, we find that these and several1662 Cell Reports 26, 1654–1667, February 5, 2019other orb6 phenotypes persist in gef1D cells. Upon inhibition of
Orb6 kinase activity in vivo, impaired exocytosis is a key Gef1-
independent phenotype, and from an unbiased quantitative
global phosphoproteomics analysis, we identified several novel
Orb6 targets related to membrane trafficking, including proteins
implicated in signaling, lipid binding, and exocytosis. Through
more detailed analysis of Orb6 phosphorylation of the exocyst
complex, we have shown that Sec3 serine-201 phosphorylation
is important for exocyst function.
Role of Gef1 in Mediating Orb6 Function
Orb6 inactivation, using either temperature-sensitive orb6-25 or
analog-sensitive orb6-as2, results in several phenotypes,
including partial ectopic localization of Cdc42-GTP to cell sides
(without complete loss from cell tips), actin disorganization, and
increased cell width and/or rounding. Cdc42 is fundamental to
multiple aspects of cell polarity, including actin organization
and exocyst function (Martin and Arkowitz, 2014); thus, it has
been proposed that ectopic Cdc42-GTP localization is a critical
mediator of orb6 phenotypes (Das et al., 2009). While we
confirmed that ectopic Cdc42-GTP localization after Orb6 inhibi-
tion requires Gef1 (Das et al., 2009), we find that ectopic Cdc42-
GTP is not the cause of increased cell width in orb6 cells,
because cell-width increases after Orb6 inactivation in wild-
type (gef1+) cells are similar to those seen in gef1D cells, which
do not have ectopic Cdc42-GTP. Our results disagree with
earlier work reporting smaller width increases in gef1D cells
compared to gef1+ cells after Orb6 inactivation (Das et al.,
2009).We do not have an explanation for these different findings,
which led us to investigate alternative mechanisms by which
Orb6 could regulate polarized growth (described later).
Orb6 and Exocytosis
In addition to the phenotypes described earlier, Orb6-inhibited
cells (both gef1+ and gef1D) are strongly impaired in exocytosis
and cease interphase cell elongation, despite enriched Cdc42-
GTP at cell tips. The exocytosis and elongation phenotypes
are likely related, as evidenced by disappearance of Bgs4 from
cell tips after Orb6 inhibition. Bgs4 disappearance from tips is
due to continued endocytosis in the absence of exocytosis,
and because Bgs4 is required for cell wall synthesis at cell
tips, this can account, at least partly, for cessation of cell
elongation.
In Orb6-inhibited cells, although exocytic trafficking of Bgs4 to
cell tips is abolished during interphase, Bgs4 accumulates at the
cell midzone during cytokinesis on either side of the primary
septum. This indicates that during cytokinesis, exocytosis
proceeds independently of Orb6 to facilitate processes such
as primary septum formation. Later, as cells progress to the
next interphase, Orb6-dependent exocytosis is required for
secretion of hydrolases to dissolve the primary septum and
separate the daughter cells. Our finding that Orb6 regulates
exocyst (described later) is consistent with exocyst mutants dis-
playing cell-separation defects, rather than cytokinesis defects
(Bendezu´ et al., 2012; Jourdain et al., 2012; Wang et al., 2002).
This, in turn, implies that targeting of secretion toward the mid-
zone during cytokinesis (e.g., for primary septum formation) in-
volves mechanisms other than exocyst (Wang et al., 2002).
Based on previous work showing redundancy of exocyst func-
tion and actin cable-based vesicle delivery in promoting efficient
exocytosis (Bendezu´ and Martin, 2011; Nakano et al., 2011;
Snaith et al., 2011), we speculate that during cytokinesis, the
abundance of actin cables contributing to the cytokinetic acto-
myosin ring (Mishra et al., 2014; Willet et al., 2015) can bypass
a need for exocyst.
The cell-separation defect of Orb6-inhibited cells is sup-
pressed by deletion of sts5, which encodes an RNA-binding
protein (Nun˜ez et al., 2016). It has been proposed that Orb6
negatively regulates the recruitment of Sts5 into ribonucleopro-
tein granules and processing bodies (P-bodies), thereby control-
ling the translational repression of Sts5-associated mRNAs
encoding proteins involved in polarized growth and cell separa-
tion (Nun˜ez et al., 2016). Because our data suggest that cell-sep-
aration defects in Orb6-inhibited cells are due to defects in
exocytosis, it is plausible that sts5D causes an upregulation inexocytosis post-cytokinesis, promoting dissolution of the pri-
mary septum and thus cell separation. Potential links between
Sts5 and exocytosis represent an interesting area for future
exploration.
Phosphoregulation of Exocyst
We demonstrated phosphorylation of exocyst Sec3 serine-201
and Sec5 serine-50 by Orb6 in multiple assays. While sec5-
S50A mutants have no detectable phenotype, sec3-S201A
mutants show clear defects in exocytosis, even though sec3-
S201A phenotypes are not as severe as sec3D phenotypes
(Bendezu´ et al., 2012). In addition, double-mutant analysis
indicates that the function of Sec3 serine-201 phosphorylation
overlaps with that of Exo70 during cell separation.
At a mechanistic level, it is not yet clear what this function is. In
both budding and fission yeast, Sec3 and Exo70 are redundantly
required for exocyst localization to the plasma membrane,
through interactions with phosphatidylinositol 4,5-bisphosphate
(PIP2) on the plasma membrane (Bendezu´ et al., 2012; He et al.,
2007; Liu et al., 2007; Zhang et al., 2008). While this raised the
possibility that Sec3 serine-201 phosphorylationmight be impor-
tant for exocyst localization, both Sec5 and Sec8 can localize to
cell tips and the septation zone in sec3-S201A exo70D cells, and
Sec3-S201A-3mCherry localizes to cell tips and to the septation
zone. Thus, Sec3 serine-201 phosphorylation is not required for
exocyst localization.
We speculate that Sec3 serine-201 phosphorylation may
modulate exocyst conformational dynamics (Heider and Mun-
son, 2012) and/or interaction with small GTPases (Wu et al.,
2008). Exocyst is regulated by Rho- and Rab-family GTPases,
as well as by protein kinases, and this regulation can alter dy-
namic aspects of exocyst assembly and/or local activation (Wu
et al., 2008; Wu and Guo, 2015). A cryo-electron microscopy
(cryo-EM) structure of budding yeast exocyst was unable to
model the N-terminal region (600 amino acids) of Sec3, sug-
gesting that this region may be more disordered or flexible
than the bulk of the exocyst complex (Mei et al., 2018; Lepore
et al., 2018). Because budding yeast and fission yeast Sec3
have only limited sequence similarity (Bendezu´ et al., 2012)
and Sec3 serine-201 is not obviously conserved in budding
yeast, it is difficult to extrapolate directly from one system to
the other. However, in this context, the budding yeast Sec3 N
terminus contains four NDR/LATS consensus sites, at least
two of which are phosphorylated in vivo (https://www.
yeastgenome.org/locus/S000000810/protein). Like budding
yeast Sec3, fission yeast Sec3 contains an N-terminal cryptic
pleckstrin homology (PH) domain (residues 1–133) involved in
PIP2 binding (Bendezu´ et al., 2012), but serine-201 lies outside
this domain. Additional work will be needed to determine
how fission yeast Sec3 serine-201 phosphorylation regulates
exocyst.
Additional Orb6 Targets
Both mass spectrometry (MS) analysis and cell phenotypes
suggest that Orb6 targets involved in exocytosis are not
restricted to exocyst proteins. Orb6 inhibition in vivo leads
to cessation of cell elongation and decreased exocyst at cell
tips, whereas sec3-S201A exo70D cells, despite impaired ACPCell Reports 26, 1654–1667, February 5, 2019 1663
secretion and cell-separation defects, can grow in a polarized
fashion and maintain exocyst at cell tips (Figures 7 and S5).
We propose that the strong phenotypes seen after Orb6 inhibi-
tion are due to the total combined changes in phosphorylation
of multiple Orb6 targets in several related pathways. In addition
to Sec3 and Sec5, Orb6 targets identified in this work include
protein kinases and proteins involved in membrane trafficking.
Nearly all of the highest-ranking phosphosites (i.e., those with
highest reproducibility and greatest fold decrease after Orb6
inhibition) match the NDR/LATS consensus (Figures 4 and S2;
Table S2), suggesting that they are direct substrates of Orb6.
In addition to exocyst, we identified Sec72, Pep7, Ppk25, and
Osh2 as Orb6 targets. Sec72 is a homolog of budding yeast
Sec7, a GEF for Arf1 ADP ribosylation factor that is important
for coat formation on nascent vesicles emanating from the Golgi
and the trans-Golgi network (Wright et al., 2014). Budding yeast
Pep7 (also called Vac1/Vps19) integrates Rab GTPase and
phosphatidylinositol 3-kinase signaling and promotes Golgi-to-
endosome transport (Peterson et al., 1999). The kinase Ppk25
does not have extensive regulatory domains, but its kinase
domain is most similar to that of the budding yeast paralogs
Kin1 and Kin2, which function in late stages of exocytosis
through phosphorylation of t-SNARE Sec9 (Elbert et al., 2005).
Budding yeast Osh2, a member of a conserved family of oxy-
sterol-binding protein-related proteins (Raychaudhuri and Prinz,
2010), facilitates endocytosis at plasma membrane regions that
contact cortical endoplasmic reticulum (Encinar Del Dedo et al.,
2017). Collectively, the functions of these proteins in budding
yeast suggest that in fission yeast, Orb6 coordinates multiple
processes related to membrane trafficking.
Although we identified several phosphosites in the previously
characterized Orb6 targets Gef1 and Sts5, none of these sites
showed significant decreased phosphorylation after Orb6 inhibi-
tion (i.e., 2-fold or greater) (Table S1). In addition, although Gef1
serine-112 was previously described as an Orb6-dependent
phosphosite in vitro (Das et al., 2015), we did not identify it as
a phosphosite in vivo. However, absence from our datasets
does not necessarily imply that Gef1 and Sts5 are not bona
fide Orb6 substrates, because global phosphoproteomics anal-
ysis is unlikely to be exhaustive.
The notion that Orb6 may have multiple roles in regulating
membrane trafficking and cell polarity is consistent with analysis
of NDR1/2 kinase function in mammalian cells. NDR1 negatively
regulates dendrite length and branching via phosphorylation of
targets including AAK1 and Rabin8 (GEF for GTPase Rab8),
which regulate vesicle-mediated trafficking (Ultanir et al.,
2012). Independently, NDR2 was shown to phosphorylate
Rabin8 to promote Rabin8-Sec15 interaction, activating Rab8
during ciliogenesis (Chiba et al., 2013). NDR2 also regulates
b1-integrin exocytosis, thus controlling integrin activation for
neurite growth and guidance (Rehberg et al., 2014). In addition,
in budding yeast, Cbk1 has been proposed to regulate more
than one step in the secretory pathway (Kurischko et al., 2008),
although some aspects of this may be controversial (Jansen
et al., 2009). Collectively, our results suggest that regulation of
exocytosis and/or secretion by NDR/LATS kinases may be a
generally conserved design principle, although specific targets
of NDR/LATS kinases may differ in different systems.1664 Cell Reports 26, 1654–1667, February 5, 2019Physiological Function of Switching off Orb6 Activity
Orb6 is the most downstream kinase of the fission yeast
morphogenesis network (MOR), a signaling pathway similar in
design to the fission yeast septation initiation network (SIN) (Si-
manis, 2015), budding yeast mitotic exit network (MEN) and
regulation of Ace2 and morphogenesis (RAM) network (Weiss,
2012), and metazoan Hippo pathway (Hansen et al., 2015). In
addition to Orb6, MOR proteins include Sog2, Mob2, Mor2,
and Pmo25, as well as the germinal-center kinase Nak1; all of
these are conserved, and all are important for regulation of cell
polarity and cell separation (Kanai et al., 2005). MOR signaling
decreases during mitosis, when cells switch polarity from tip
growth to the midzone for cell division, and it increases again
after completion of cytokinesis, coincident with cell separation
(Kanai et al., 2005; Ray et al., 2010). Attenuation of MOR
signaling in mitosis depends on SIN, and there is compelling
evidence that mutual antagonism between MOR and SIN is crit-
ical for coordinating changes in cell polarity and cytoskeletal
reorganization through the cell cycle (Ray et al., 2010). At the
same time, the targets of MOR that execute these changes
have generally remained obscure. Based on the results pre-
sented here, we propose a simple model in which Orb6 regula-
tion of exocytosis is a key output of MOR signaling. According
to this view, during interphase, Orb6 promotes polarized exocy-
tosis at cell tips, while during mitosis, decreased Orb6 activity
shuts down exocytosis at tips, allowing Orb6-independent redis-
tribution of secretion toward the cell midzone. After cytokinesis
(effectively, the next interphase), the return of Orb6 activity spe-
cifically promotes exocytosis of hydrolases into the septation
zone, dissolving the primary septum for daughter-cell separation
and allowing resumption of growth at cell ends. While further
functional characterization of Orb6 targets awaits elucidation,
we speculate that by coordinating multiple kinase signaling
and vesicle-mediated trafficking pathways, Orb6 may function
as an interphase-specific master regulator of membrane traf-
ficking and exocytosis, thus helping to drive transitions in cellular
organization between interphase and mitosis.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Fission Yeast Strains and Construction
Mating for genetic crosses (Ekwall and Thon, 2017) was performed on SPA5S plates with supplements at 45 mg/L. Crosses were
performed using tetrad dissection or random spore analysis. Tagging and deletion of genes were performed using PCR-based
methods (Ba¨hler et al., 1998). The orb6-as2 strain was generated by transformation of an NdeI-BamHI restriction fragment containing
the orb6-as2 coding sequence (from pKS1439; see below) into an orb6-25 strain. Selection was performed at 37C, which is non-
permissive for growth of orb6-25 cells. Positive clones were sequenced to ensure correct replacement of the orb6-25 allele by
orb6-as2. All strains used in this study are listed in Table S3. Throughout this work, we use the term ‘‘wild-type’’ to refer to control
strains that have wild-type alleles relative to the mutants with which they are compared in the same figure or panel. Therefore, strains
described as ‘‘wild-type’’ can have additional auxotrophies and/or fluorescent-reporter alleles; full genotypes are indicated in strain
list.
METHODS DETAILS
Yeast culture
Standard fission yeast methods were used throughout (Forsburg and Rhind, 2006; Petersen and Russell, 2016). Cultures for live-cell
imaging and in vitro kinase assays were grown in YE5S rich medium (using Bacto yeast extract; Becton Dickinson). SILAC cultures
were grown in Edinburgh Minimal Medium with appropriate supplements. Supplements such as adenine, leucine, and uracil were
used at 175 mg/L. Solid media used 2% Bacto agar (Becton Dickinson). Normal arginine and lysine supplements were used at
40 mg/L and 30 mg/L, respectively. ‘‘Heavy’’ 13C6 –labeled L-arginine-HCl (
13C6 –labeled; Sigma; 643440) and
13C6
15N2 –labeled
L-lysine-2HCl (13C6
15N2–labeled; Sigma; 608041) supplements were used at the same concentration as their light counterparts.
SILAC cell cultures were grown as described previously (Bicho et al., 2010; Macek et al., 2017). To inhibit Orb6 kinase activity in vivo,
3-BrB-PP1 (Toronto Research Chemicals; A602985), 3-MB-PP1 (Toronto Research Chemicals; A602960), 1-NM-PP1 (Toronto
Research Chemicals; A603003) dissolved in methanol were each used at a final concentration of 30 mM. 3-MB-PP1 and 1-NM-
PP1were only sparingly soluble inmethanol in normal stock solutions, whereas 3-BrB-PP1 was considerably more soluble; therefore
we used 3-BrB-PP1 for Orb6 inhibition in all other experiments. For imaging experiments involving hydroxyurea, cells were grown in
YE5S media containing 12 mM hydroxyurea (prepared fresh; Sigma; H8627), starting at 1.4 hr before the beginning of imaging. For
actin depolymerization, Latrunculin A (Alpha laboratories; 129-04361) was added to cells at a final concentration of 50 mM in growth
medium (made from a 25 mM stock in DMSO), 10 min before addition of 3-BrB-PP1.
Plasmid construction
Two DNA fragments encoding N- and C-terminal regions of Orb6 were amplified by PCR from fission yeast genomic DNA. Both DNA
sequences contain a 25-nucleotide overlapping sequence and a single point mutation (orb6-as2) corresponding to an M170A mu-
tation in the amino-acid sequence. The two fragments were assembled with plasmid pREP41X using Gibson assembly kit (NEB;
E2611S), to make plasmid pKS1439. Sec3 and Sec5 sequences amplified from fission yeast genomic DNA were cloned into
pGEX4T-1 vector and expressed as GST fusion proteins in E.coli strain BL21(DE3)-RIL (Agilent).
Microscopy sample preparation and imaging
Exponentially growing cells cultured at 25C were used in all imaging experiments, unless otherwise stated. Fluorescence live-cell
imaging was performed either in coverslip dishes (MatTek; P35G-0.170-14-C.s) or 4-chamber glass bottom micro-slides (Ibidi;
80427). Imaging dishes/slides were coated with 1 mg/mL soybean lectin (Sigma; L1395) for 10 min and washed with appropriate me-
dium to remove excess lectin. Log-phase culture was added to dishes/slides and allowed to attach to the coverslip bottom for 15min.
The dishes/slides were washed extensively with media using aspiration with at least 3 full exchanges of media (approximately 1 mL
each). Finally, 500 mL of mediumwas added to the dish/slide before imaging. Nearly all live-cell fluorescence imaging was done usinge3 Cell Reports 26, 1654–1667.e1–e7, February 5, 2019
a custom spinning-disk confocal microscope unit composed of Nikon TE2000 microscope base, attached to a modified Yokogawa
CSU-10 unit (Visitech) and an iXon+ Du888 EMCCD camera (Andor), 100x/1.45 NA Plan Apo objective (Nikon), Optospin IV filter
wheel (Cairn Research), MS-2000 automated stage with CRISP autofocus (ASI), and thermo-regulated chamber maintained at
25C (OKOlab). Metamorph software was used to control the spinning-disc confocal microscope. FRAP was performed on a Zeiss
Airyscanmicroscope (LSM880, AxioObserver, alpha Plan-ApoChromat 100x/1.46 Oil DICM27 Elyra). GFP signal was detected using
488 nm line of an Argon laser and a 495-550 nm bandpass emission filter (number of iterations = 5, acquisition time interval 30 s). To
measure width of live cells attached to coverslip dishes, FITC-dextran (Sigma: FD500S) was added to the medium at final
concentration of 3.5mg/mL and imaged using 488nm excitation laser.
Calcofluor stainingwas performed according to standard protocol (Hagan, 2016). Briefly, 900 mL of log-phase culture was added to
100 mL 30% formaldehyde solution (Sigma; F1268) and kept on ice for 10 min. Cells were pelleted and washed three times using
ice-cold PBS buffer. The final pellet was resuspended in 50 mL PBS. 1.5mL of cell suspension was mixed with 1.5 mL of 10 mg/mL
Calcofluor solution (Fluorescence Brightener 28; Sigma; F3543). Calcofluor-stained cells were imaged using a Zeiss Axiolmage
microscope with 100X/1.46NA alpha-Plan Apochromat objective, CoolLED pE-300 lightsource and Hamamatsu Flash 4 camera.
Micromanager acquisition software was used to control the Zeiss microscope.
For imaging experiments, we define a ‘‘biological replicate’’ as the collective imaging of all relevant, validated strains on a single
occasion under the specific conditions stated. In a given (replicate) imaging experiment for a given strain, multiple independent fields
were imaged, with multiple cells per field. For presentation in figures, representative cells were chosen.
Microscopy image analysis
ImageJ (Fiji) was used to process all acquired raw images. All images and videos shown are maximum projections of eleven Z sec-
tions with 0.7 mmstep-size. ImageJ StackReg plugin was used for rigid body registrations. Kymographs was generated using Reslice
and KymoResliceWide plugin in ImageJ. Cell-width and cell-elongation measurements were performed manually using the Line tool
in ImageJ. Cell volume was estimated using the measured length and width of individual cells, with the approximation that each cell
can be considered as a cylinder plus one hemisphere at each end. FRAP of GFP-Psy1was quantified bymeasuring total fluorescence
signal within the bleached portion of the plasma membrane (orange portion of linescan in Figure 3C) and normalizing values to the
signal for the same region prior to bleaching. Image formatting and assembly were performed using Photoshop (Adobe) and
Illustrator CS3 or CS6 (Adobe). Videoswere edited using ImageJ andQuickTime (Apple). Graphswere created usingGraphPad Prism
software and Microsoft Excel.
ACP assay
ACP assays were performed as described previously (Wang et al., 2002). Cells were grown to mid-log phase in YE5S at 25C. Cells
were washed twice in pre-warmed YE5S medium, and all strains were adjusted to OD595 = 0.25. The cells in fresh media were
cultured in a 25C shaking water bath. At indicated time points, cell density (OD595) was measured, and 1 mL culture was centrifuged
to pellet the cells. 300 mL cell-free culture medium was incubated with 400 mL of phosphatase substrate solution (3 tablets of
phosphatase substrate (Sigma; S0942) dissolved in 20 mL of 0.1 M sodium acetate pH 4.0, pre-warmed to 32C). The reaction
was stopped by addition of 400 mL of 1 M NaOH. OD405 was measured against a blank consisting of fresh YE5S medium without
cells, mixed with an appropriate volume of phosphatase substrate solution. For each time point, ACP activity (OD405) was normalized
to cell density (OD595). In the experiments in Figure 3B, four independent biological replicates were performed for wild-type and orb6-
as2, and two independent biological replicates for orb6-as2 gef1D. In the experiments in Figure 7A, three independent replicates
were performed for all strains.
Sample preparation for global phosphoproteomics
SILAC cultures supplemented with ‘‘heavy’’ arginine and lysine were grown for at least 8 generations to ensure complete isotopic
labeling. Light- and heavy-labeled SILAC cultures were grown to OD595 0.75 and then treated with either methanol or 30 mM
3-BrB-PP1 for 3 hr. In two replicate experiments, heavy-labeled cultures were treated with 3-BrB-PP1, and light-labeled cultures
were treated with methanol; in a third replicate, heavy-labeled cultures were treated with methanol, and light-labeled cultures
were treated with 3-BrB-PP1. Cells were harvested by centrifugation and washed once with STOP buffer (10 mM EDTA, 50 mM
NaF, 150mMNaCl, 1mMNaN3). Pelleted cells were resuspended inmilliQ H2O at 400mg/mL concentration and flash-frozen in liquid
nitrogen. Mechanical lysis of frozen cells (cryogrinding) was performed under liquid nitrogen in a SPEX SamplePrep LLC 6870
Freezer/mill (sample pre-cool for 2 min, 10 rounds of ‘‘run’’ and ‘‘cool’’ cycle each for 2 min, beat rate = 10). 800 mg of light-
and heavy-labeled cell powders were individually solubilized in denaturation buffer (6 M urea, 2 M thiourea, 10 mM Tris-HCl pH
8.0) for 1 hr at room temperature and centrifuged at 4,500 x g for 15 min to obtain a clear supernatant. Protein concentration from
both samples was measured using Bradford assay.
For protein abundance measurement of the SILAC samples, light- and heavy-labeled cell lysates (5 mg each) were mixed, and
50 mg of the mixed protein lysate was separated by SDS-PAGE on Bolt 4%–12% Bis-Tris Gel (Thermo Fisher Scientific;
NW04120BOX). The protein gel was stained by Coomassie brilliant blue and the entire gel lane was excised into 10 bands and
processed for protein abundance analysis (see In-Gel Digestion for Mass Spectrometry).Cell Reports 26, 1654–1667.e1–e7, February 5, 2019 e4
For SILAC phosphopeptide quantification, the remaining 9.95 mg of the mixed protein lysate was reduced in 1 mM DTT for 1 hr at
room temperature. The reduced lysate was further alkylated in 5.5 mM iodoacetamide (Sigma; I1149) for 1 hr at room temperature in
the dark. In-solution protein digestions were performed using Lysyl Endopeptidase (LysC; Waco Chemicals; 129-02541) and trypsin
(Thermo-scientific; 90057) in two stages. First, the lysate was digested by 90 mg of LysC for 3 hr at room temperature. The lysate was
thendiluted 5 times to final concentration of 1.6Murea/ 0.4M thiourea. 90mgof trypsinwasadded to the lysate and incubated for 24 hr
at room temperature. Digestion was terminated by acidification to final concentration of 0.4% trifluoroacetic acid (TFA; Sigma; 6508).
Peptide fractionation
Strong cation exchange (SCX) fractionation was performed as in (Gruhler et al., 2005) with some modifications. Doubly digested
mixed lysate was fractionated using a Resource S SCX column (1 mL, GE Healthcare) in a A¨KTA protein purification system (GE
Healthcare). Briefly, the mixed lysate was loaded onto the SCX column equilibrated in Solvent A (5 mM potassium dihydrogen phos-
phate, 30% acetonitrile (ACN; Fisher Chemicals, A955-212), pH 2.7 with TFA) at a flow rate of 1 mL/min. Flow-through during loading
was kept for subsequent phosphopeptide enrichment. Peptides bound to the column were eluted as 2 mL fractions with a 0%–50%
linear gradient of Solvent B (350 mM potassium chloride, 5 mM potassium dihydrogen phosphate, 30% ACN, pH 2.7 using TFA) at a
flow rate of 1mL/min, over a period of 30min. Dilute fractions, based on estimation from the chromatogram, were pooled together for
subsequent phosphopeptide enrichment.
Phosphopeptide enrichment
TiO2 phosphopeptide enrichment was performed as in (Larsen et al., 2005) with some modification. Each SCX fraction, including the
flow-through and pooled fractions, was processed individually. Flow-through fraction was incubated with 10 mg TiO2 beads slurry
(Titansphere; GL Sciences; 5020-75010) in 30 mg/mL 2,5 dihydrobenzoic acid (Sigma; 149357) and 80% ACN, whereas other frac-
tions were incubated with 5 mg TiO2 beads slurry and incubated at room temperature for 30 min. TiO2 beads were concentrated by
1 min centrifugation at 13,000 rpm and supernatant was removed. TiO2 beads were then washed with washing solution I (30% ACN,
3% TFA) and pelleted. TiO2 beads were then resuspended with washing solution II (80%, ACN, 0.1% TFA) and transferred to C8-
stage tip (1 mm2 Empore C8 in 200 mL pipette tip). Washing solution II was removed from the stage-tip by centrifugation at
4,000rpm for 2-3 min. Phosphopeptides bound to the TiO2 beads were eluted three times by passing through elution solution
(40% ammonium hydroxide (Sigma; 338818), 60% ACN). The eluates were loaded onto C18-stage tip (1mm2 Empore C18 in
200 mL pipette tip) pre-washed with 0.1% TFA. The stage tips were washed with 50 mL 0.1% TFA and stored at 20C until further
use. Because the flow-through fraction contains themost abundant phosphopeptide fraction, two additional rounds of phosphopep-
tide enrichment were performed on the flow-through fraction with fresh TiO2 beads (10 mg).
In-gel digestion for MS
Coomassie-stained gel slices were destained and digested in-gel as described (Shevchenko et al., 1996). Briefly, the bands were
destained by 3-4 rounds of incubation in 25 mM ammonium bicarbonate in 50% ACN until the last trace of Coomassie blue was
removed. Gel slices were reduced in 10 mM DTT for 30 min at 37C, alkylated in 55 mM iodoacetamide for 30 min at room temper-
ature in the dark, and digested overnight at 37Cwith 12.5 ng/mL trypsin. Digestion mediumwas then acidified by TFA and the eluted
peptides were desalted using C18-stage tip as described (Rappsilber et al., 2003).
LC-MS/MS
Peptides were eluted in 40 mL of 80% acetonitrile in 0.1% TFA and then concentrated to 1 mL by vacuum centrifugation (Concentrator
5301, Eppendorf, UK). Samples were then diluted to 5 mL with 0.1% TFA and prepared for LC-MS/MS analysis. LC-MS-analyses
were performed on a Q Exactive mass spectrometer (Thermo Fisher Scientific, UK) and on an Orbitrap Fusion Lumos Tribrid
Mass Spectrometer (Thermo Fisher Scientific, UK). Both were coupled on-line to Ultimate 3000 RSLCnano Systems (Dionex, Thermo
Fisher Scientific, UK). For samples that were analyzed by Q Exactive, peptides were separated by an analytical column with a self-
assembled particle frit (Ishihama et al., 2002) and C18 material (ReproSil-Pur C18-AQ 3 mm; Dr. Maisch, GmbH, Germany) that was
packed into a spray emitter (75 mm ID, 8 mm opening, 300 mm length; New Objective) using an air-pressure pump (Proxeon
Biosystems, USA). The column was maintained at stable temperature (40C) with the appropriate column oven (Sonnation,
Germany). Peptides that were analyzed by Fusion Lumos were separated on a 50cm EASY-Spray column (Thermo Fisher Scientific,
UK) assembled in an EASY-Spray source and operated at 50C. In both cases, mobile phase A consisted of 0.1% formic acid in water
while mobile phase B consisted of 80% acetonitrile and 0.1% formic acid. Peptides were loaded at a flow rate of 0.5 mL min-1 (for
samples on Q Exactive) and 0.3 mL min-1 (for samples on Fusion Lumos) and eluted at a flow rate was 0.2 mL min-1according to
the following gradient: 2 to 40% buffer B in 120 min, then to 95% in 11 min.
For Q Exactive, FTMS spectra were recorded at 70,000 resolution (scan range 300-1700m/z), and the ten most intense peaks with
chargeR 2 of theMS scan were selected with an isolation window of 2.0 Thomson for MS2 (filling 1.0E6 ions for MS scan, 5.0E4 ions
for MS2, maximum fill time 60ms, dynamic exclusion for 50 s). For Orbitrap Fusion Lumos, survey scans were performed at 120,000
resolution (scan range 400-1900m/z) with an ion target of 4.0e5. MS2 was performed in the ion trap with ion target of 1.0e4 and HCD
fragmentation with normalized collision energy of 27 (Olsen et al., 2007). The isolation window in the quadrupole was 1.4. Only ions
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TheMaxQuant software platform version 1.5.2.8 was used to process raw files, and searchwas conducted againstSchizosacchar-
omyces pombe complete/reference proteome set of Pombe database (released in August, 2013), using the Andromeda search
engine. The first search peptide tolerance was set to 20 ppm while the main search peptide tolerance was set to 4.5 ppm. Isotope
mass tolerance was 2 ppm and maximum charge to 7. Maximum of two missed cleavages were allowed. Carbamidomethylation of
cysteine was set as fixed modification. Oxidation of methionine, acetylation of the N-terminal and phosphorylation of serine,
threonine and tyrosine were selected as variable modifications. When SILAC labeled samples were analyzed, the multiplicity was
set to 2 and the appropriate labels were selected. Peptide and protein identifications were filtered to 1% FDR.
Global phosphoproteomics data analysis and presentation
For summaries of global phosphoproteomics results, presented in Table S1, selected MaxQuant fields from individual biological-
replicate experiments are shown in separate tabs (full datasets containing all fields are available via the PRIDE repository; see
below). To generate the ‘‘Orb6 inhibition summary’’ tab, only phosphosites with localization probability greater than or equal to
0.75 from a given replicate experiment were copied into the summary tab. This decreased the number of quantified phosphosites
after Orb6 inhibition from 8,134 to 6,300. In the summary tab, the mean log2(fold-change) in phosphorylation of a given phospho-
site after Orb6 inhibition was calculated in one of two ways, depending on whether the log2(fold-change) values in a replicate
experiment included normalization to protein abundance. For phosphosites with values normalized to protein abundance, only
the protein-normalized values were used to calculate mean log2(fold-change). That is, non-protein-normalized values for the
same phosphosite were not used in the calculation, even though these values are listed in the summary tab. For phosphosites
lacking any log2(fold-change) values normalized to protein abundance, the non-protein-normalized values were used in the calcu-
lation. The mean of the log2(fold-change) was used rather than the log2(mean fold-change) in order to decrease effects of outlier
data.
For ranking of Orb6-dependent phosphosites (based on fold-change in phosphorylation after Orb6 inhibition) in relation to the
NDR/LATS consensus motif, presented in Table S2, different ‘‘stringency’’ tabs were made in order to take into consideration the
reproducibility of phosphosite quantification in different biological-replicate experiments. To populate the different tabs in Table
S2, data from the ‘‘Orb6_inhibition summary’’ tab in Table S1 were used as initial input. In order for a given phosphosite to be
included in the ‘‘Lowest Stringency’’ tab, three conditions had to be satisfied. First, the phosphosite was required to be quantified
in at least one of three biological-replicate experiments. Second, the phosphosite was required to have a greater-than-two-fold
decrease after Orb6 inhibition (i.e., the ‘‘mean log2(fold-change) after Orb6 inhibition’’ was required to be more negative
than 1.0). Third, the same phosphosite was required not to have a greater-than-two-fold decrease in the corresponding control
experiment in which wild-type cells were treated with 3-BrB-PP1 (i.e., the ‘‘mean log2(fold-change) after 3-BrB-PP1 addition’’ in
the Control tab in Table S1 was not allowed to be more negative than 1.0). In order for a given phosphosite to be included in the
‘‘Medium Stringency’’ tab, the previous latter two conditions also applied, but the phosphosite was required to be quantified in at
least two biological replicates. Similarly, in order for a given phosphosite to be included in the ‘‘Highest Stringency’’ tab, the same
latter two conditions also applied, but the phosphosite was required to be quantified in all three biological replicates. Based on
these conditions, all phosphosites in the ‘‘Highest Stringency’’ tab are also present in the ‘‘Medium Stringency’’ tab, and all phos-
phosites in the ‘‘Medium Stringency’’ tab are also present in the ‘‘Lowest Stringency’’ tab. Within each tab, phosphosites were
then ranked by fold-decrease after Orb6 inhibition, and then classified according to similarity to the NDR/LATS consensus motif,
HxR/H/KxxS/T. Alignment of sequences containing the NDR/LATS consensus was performed using MegAlignPro version 15
(DNASTAR).
GO analysis for Figure 4C was carried out using Generic Gene Ontology (GO) Term Finder. Fold-enrichment for each GO term
identified from our input cluster of genes is defined as the ratio of (frequency of the GO term within the cluster) to (frequency of
the GO term within the genome).
Immunoprecipitation of Sec5-3mCherry
Cells expressing Sec5-3mCherry in SILAC background were grown in two separate cultures supplemented with light and heavy
isotopes for 8 generations. Light- and heavy-labeled cultures were treated with methanol and 30 mM 3-BrB-PP1 respectively, for
45 min. The cells were washed with STOP buffer and resuspended in lysis buffer (50 mM Tris-HCl pH 7.5, 50 mM NaF, 150 mM
NaCl, 20 mM Na-b-glycerophosphate, 0.2% Triton X-100, 1 mM Na3VO4, 1 mM EDTA, 10 mg/mL each of ‘CLAAPE’ protease
inhibitors (chymostatin, leupeptin, aprotinin, antipain, pepstatin, E-64), 2 mM AEBSF, 2 mM benzamidine, 50 nM Calyculin A,
50 nM Okadaic acid and 2 mM PMSF) at a concentration of 1 g/mL. The cell suspension was drop-frozen in liquid nitrogen and
mechanically lysed using SPEX Freezer/Mill. Light- and heavy-labeled cell powders were resuspended in lysis buffer and cell
extracts were cleared by 23 15 min centrifugation at 4,000 x g in a Beckman Avanti J-26 centrifuge using a JLA 8.1000 rotor. Protein
content in each sample was measured and samples are mixed at 1:1 ratio. The mixed cell extract was incubated with Protein G Dy-
nabeads (Thermo Fisher Scientific; 10003D), covalently crosslinked to homemade affinity-purified rabbit anti-tdimer2 using dimethyl
pimelimidate, for 1 hr. Dynabeads were then washed five times with lysis buffer. Proteins were eluted from Dynabeads by 10 min
incubation at 65C in Laemmli sample buffer. Eluted proteins were separated by SDS-PAGE on a Bolt 4%–12% Bis-Tris Gel.
The gel was stained by Coomassie Brilliant Blue, and gel bands were excised and processed according to the in-gel digestion
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Purification of GST-Sec3 and GST-Sec5
Expression was induced in 500mL bacterial culture at OD595 = 0.8 by addition of 0.2mM IPTG, followed by growth for additional 24 hr
at 18C. Cells were harvested by centrifugation and resuspended in lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 5% glycerol,
5 mM EDTA, 3 mM DTT, 0.1% Triton X-100, 200 mg/mL lysozyme, benzonase (10 units/mL), 10 mg/mL each of ‘CLAAPE’ protease
inhibitors). The cells were then lysed by sonication. Cell extracts were clarified by centrifugation at 15,000 rpm at 4C for 30 min.
Cleared lysates were then incubated with glutathione-agarose (Sigma; G4510). Glutathione-agarose with bound GST proteins
was then placed in a column and washed with 20 bead-volumes of wash buffer (50 mM Tris-HCl pH 8.0, 300 mM NaCl, 100 mM
KCl, 10% glycerol, 5 mM EDTA, 3 mM DTT, 0.1% Triton X-100). GST fusion proteins were then eluted with elution buffer (50 mM
Tris-HCl pH 8.0, 300 mM NaCl, 10% glycerol, 2 mM EDTA, 3 mM DTT, 20 mM glutathione) in 1 mL fractions. Protein-rich fractions
were pooled together and concentrated using Amicon Ultra-4 centrifugal filter unit with Ultracel-30 membrane (Millipore;
UFC803024).
In vitro kinase assays
Orb6 in vitro kinase assays were performed using immunoprecipitates of the Orb6 coactivator Mob2, as immunoprecipitation using
antibody bound to Orb6 can inhibit kinase activity (Wiley et al., 2003). Cells expressing Mob2-GFP in sts5D and sts5D orb6D back-
grounds were grown in YE5S medium to mid-log-phase, harvested and washed with STOP buffer. 1x107 Cells were pelleted into
1.5 mL screw-cap microfuge tubes and snap frozen in liquid nitrogen. 200 mL of precooled lysis buffer (50 mM Tris-HCl pH 7.5,
50 mM NaF, 150 mM NaCl, 20 mM Na-b-glycerophosphate, 0.2% Triton X-100, 1 mM Na3VO4, 1 mM EDTA, 10 mg/mL each of
‘CLAAPE’ protease inhibitors, 2 mM AEBSF, 2 mM benzamidine, 50 nM calyculin A, 50 nM okadaic acid and 2 mM PMSF) and
500 mL of 0.5 mm zirconia beads were added to the microfuge tubes and disrupted by bead beating in Ribolyser (Hybaid) at
4C using two cycles of 35 s at maximum setting (6.5). 350 mL of lysis buffer was added into the tube and mixed thoroughly. Cell
lysates were collected by centrifugation through a hole pierced at the bottom of the microfuge tube. Cell lysates were cleared by
centrifugation at 13,000 rpm for 6 min at 4C. 550 mL of cell lysates were incubated with 10 mL of Protein G Dynabeads, coupled
to homemade affinity-purified Sheep anti-GFP, for 1 hr at 4C. Dynabeads were then washed 3 times using lysis buffer and 3 times
using kinase buffer (50 mMTris-HCl pH 7.5, 100mMNaCl, 10mMMgCl2, 1 mMMnCl2, 10mMATP, 20mMNa-b-glycerophosphate,
1mMNa3VO4, 10 mg/mL each of ‘CLAAPE’ protease inhibitors). Dynabeadswere then incubatedwith 5 mL of recombinant GST-Sec3
and GST-Sec5 in 20 mL kinase buffer at 30C for 30 min. The kinase reaction was stopped and recovered from Dynabeads by
incubation in Laemmli sample buffer at 65C for 10 min. Kinase reactions and controls were separated on Bolt 4%–12% Bis-Tris
gel and stained with Coomassie. Bands corresponding to GST-Sec3 and GST-Sec5 were excised and processed according to
in-gel digestion protocol.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical tests
Statistical analyses in Figures 1C and 1E–1G were determined by two-tailed unpaired Mann–Whitney test, using GraphPad Prism
software (see Microscopy Image Analysis). Statistical significance in Figure 4C was determined by Generic Gene Ontology (GO)
Term Finder (see phosphosite ranking and GO analysis as described earlier).
DATA AND SOFTWARE AVAILABILITY
The MS proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Vizcaı´no et al., 2016) partner
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